Article
Paridiprubart inhibits TLR4-dependant NF-κB activation by multiple pathogens
medRxiv · 2023 · Malty, R.; Hilbe, R.; Ahn, S.; Kesselman, L.; Lam, J.; Kasawara, K.; Costa, L.; Rajakulendran, N.; Gordon, B.; Brooks, M.; Mubareka, S.; Tancevski, I.; Gray-Owen, S. D.
Key facts
| Title | Paridiprubart inhibits TLR4-dependant NF-κB activation by multiple pathogens |
|---|---|
| First author | Malty, R.; Hilbe, R.; Ahn, S.; Kesselman, L.; Lam, J.; Kasawara, K.; Costa, L.; Rajakulendran, N.; Gordon, B.; Brooks, M.; Mubareka, S.; Tancevski, I.; Gray-Owen, S. D. |
| Journal | medRxiv |
| Published | Jun 27, 2023 |
| DOI | 10.1101/2023.06.27.545921 |
| Devices mentioned | 211875, K870636, K964560 |
| Product codes mentioned | JCJ, JJH, JSC, JSD, JSG, JSH, JSJ, JSO, KZI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1